Literature DB >> 28266810

Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain.

D Fabregat-Safont1, I Fornís2, M Ventura2, C Gil2, N Calzada2, J V Sancho1, F Hernández1, M Ibáñez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28266810     DOI： 10.1002/dta.2182

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN： 1942-7603            Impact factor:   3.345


× No keyword cloud information.
  4 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900).

Authors:  D Fabregat-Safont; X Carbón; M Ventura; I Fornís; E Guillamón; J V Sancho; F Hernández; M Ibáñez
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

3.  In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats.

Authors:  David Fabregat-Safont; María Mata-Pesquera; Manuela Barneo-Muñoz; Ferran Martinez-Garcia; Marie Mardal; Anders B Davidsen; Juan V Sancho; Félix Hernández; María Ibáñez
Journal:  Commun Biol       Date:  2022-02-24

4.  Drug checking services for people who use drugs: a systematic review.

Authors:  Nazlee Maghsoudi; Justine Tanguay; Kristy Scarfone; Indhu Rammohan; Carolyn Ziegler; Dan Werb; Ayden I Scheim
Journal:  Addiction       Date:  2021-12-12       Impact factor: 7.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.